| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
ectonucleotide pyrophosphatase/phosphodiesterase 1 | 0.498 | 0.808 | 5.0E-08 |
|
disease | 0.700 | moderate | 0.786 | 0 | 0 | 2001 | 2019 | ||||||||
|
agouti related neuropeptide | 0.488 | 0.769 | 7.0E-04 |
|
disease | 0.700 | None | 0.938 | 0 | 0 | 1997 | 2019 | ||||||||
|
uncoupling protein 3 | 0.619 | 0.577 | 9.6E-10 |
|
disease | 0.700 | None | 0.907 | 0 | 0 | 1998 | 2018 | ||||||||
|
nuclear receptor subfamily 0 group B member 2 | 0.474 | 0.808 | 8.3E-06 |
|
disease | 0.690 | limited | 1.000 | 0 | 0 | 2001 | 2020 | ||||||||
|
CART prepropeptide | 0.576 | 0.692 | 9.4E-02 |
|
disease | 0.500 | None | 0.917 | 0 | 0 | 1999 | 2017 | ||||||||
|
ghrelin and obestatin prepropeptide | 0.517 | 0.769 | 1.4E-11 |
|
disease | 0.500 | None | 0.923 | 0 | 0 | 2001 | 2019 | ||||||||
|
adrenoceptor beta 3 | 0.533 | 0.731 | 2.5E-07 |
|
disease | 0.500 | None | 0.905 | 0 | 0 | 1995 | 2019 | ||||||||
|
syndecan 3 | 0.711 | 0.654 | 0.41 |
|
disease | 0.440 | None | 0.750 | 0 | 0 | 2006 | 2018 | ||||||||
|
proprotein convertase subtilisin/kexin type 1 | 0.548 | 0.615 | 2.7E-09 |
|
disease | 0.700 | None | 0.857 | 1 | 0 | 1997 | 2018 | ||||||||
|
SH2B adaptor protein 1 | 0.566 | 0.731 | 0.97 |
|
disease | 0.700 | moderate | 0.906 | 1 | 0 | 2009 | 2020 | ||||||||
|
estrogen receptor 1 | 0.324 | 0.962 | 1.00 |
|
disease | 0.600 | None | 0.979 | 1 | 0 | 2001 | 2020 | ||||||||
|
sirtuin 3 | 0.488 | 0.731 | 1.6E-04 |
|
disease | 0.600 | None | 1.000 | 1 | 0 | 2011 | 2020 | ||||||||
|
sirtuin 1 | 0.378 | 0.885 | 8.7E-02 |
|
disease | 0.600 | None | 1.000 | 1 | 0 | 2008 | 2020 | ||||||||
|
C-C motif chemokine ligand 2 | 0.321 | 0.962 | 0.61 |
|
disease | 0.600 | None | 1.000 | 1 | 0 | 2005 | 2020 | ||||||||
|
lipoprotein lipase | 0.474 | 0.808 | 1.3E-09 |
|
disease | 0.600 | None | 0.949 | 1 | 0 | 1995 | 2019 | ||||||||
|
C-reactive protein | 0.299 | 0.962 | 3.7E-03 |
|
disease | 0.600 | None | 0.980 | 1 | 0 | 2001 | 2020 | ||||||||
|
insulin receptor substrate 1 | 0.488 | 0.769 | 2.4E-02 |
|
disease | 0.600 | None | 0.969 | 1 | 0 | 1995 | 2019 | ||||||||
|
lipopolysaccharide binding protein | 0.525 | 0.808 | 4.2E-15 |
|
disease | 0.600 | None | 1.000 | 1 | 0 | 2010 | 2019 | ||||||||
|
cannabinoid receptor 1 | 0.446 | 0.808 | 0.51 |
|
disease | 0.600 | None | 0.982 | 1 | 0 | 2005 | 2020 | ||||||||
|
intercellular adhesion molecule 1 | 0.364 | 0.962 | 3.5E-02 |
|
disease | 0.590 | None | 1.000 | 1 | 0 | 2002 | 2019 | ||||||||
|
cytochrome P450 family 2 subfamily E member 1 | 0.459 | 0.885 | 8.1E-09 |
|
disease | 0.580 | None | 1.000 | 1 | 0 | 1998 | 2019 | ||||||||
|
pro-melanin concentrating hormone | 0.615 | 0.808 | 0.11 |
|
disease | 0.540 | None | 1.000 | 1 | 0 | 2001 | 2019 | ||||||||
|
coagulation factor II, thrombin | 0.415 | 0.885 | 1.1E-03 |
|
disease | 0.540 | None | 1.000 | 1 | 0 | 2007 | 2015 | ||||||||
|
acyl-CoA synthetase long chain family member 1 | 0.617 | 0.577 | 1.5E-03 |
|
disease | 0.520 | None | 1.000 | 1 | 0 | 1992 | 2015 | ||||||||
|
neuropeptide Y receptor Y5 | 0.691 | 0.462 | 6.4E-03 |
|
disease | 0.520 | None | 0.750 | 1 | 0 | 1996 | 2007 |